Standard BioTools Current Ratio 2010-2024 | LAB
Standard BioTools current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Standard BioTools Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2024-09-30 |
$0.45B |
$0.12B |
3.76 |
2024-06-30 |
$0.48B |
$0.12B |
3.88 |
2024-03-31 |
$0.55B |
$0.12B |
4.51 |
2023-12-31 |
$0.16B |
$0.11B |
1.45 |
2023-09-30 |
$0.17B |
$0.05B |
3.30 |
2023-06-30 |
$0.18B |
$0.05B |
3.91 |
2023-03-31 |
$0.20B |
$0.04B |
4.45 |
2022-12-31 |
$0.21B |
$0.04B |
4.81 |
2022-09-30 |
$0.23B |
$0.05B |
4.96 |
2022-06-30 |
$0.25B |
$0.04B |
5.87 |
2022-03-31 |
$0.07B |
$0.05B |
1.55 |
2021-12-31 |
$0.07B |
$0.05B |
1.45 |
2021-09-30 |
$0.07B |
$0.05B |
1.55 |
2021-06-30 |
$0.08B |
$0.05B |
1.48 |
2021-03-31 |
$0.10B |
$0.05B |
1.80 |
2020-12-31 |
$0.12B |
$0.05B |
2.17 |
2020-09-30 |
$0.12B |
$0.04B |
2.87 |
2020-06-30 |
$0.08B |
$0.04B |
2.05 |
2020-03-31 |
$0.08B |
$0.04B |
2.33 |
2019-12-31 |
$0.10B |
$0.03B |
2.93 |
2019-09-30 |
$0.10B |
$0.03B |
2.89 |
2019-06-30 |
$0.11B |
$0.04B |
2.86 |
2019-03-31 |
$0.11B |
$0.03B |
3.26 |
2018-12-31 |
$0.13B |
$0.04B |
3.38 |
2018-09-30 |
$0.07B |
$0.04B |
1.85 |
2018-06-30 |
$0.08B |
$0.04B |
2.05 |
2018-03-31 |
$0.08B |
$0.03B |
2.40 |
2017-12-31 |
$0.10B |
$0.03B |
2.83 |
2017-09-30 |
$0.10B |
$0.03B |
3.02 |
2017-06-30 |
$0.08B |
$0.03B |
2.31 |
2017-03-31 |
$0.09B |
$0.03B |
2.75 |
2016-12-31 |
$0.10B |
$0.03B |
3.28 |
2016-09-30 |
$0.11B |
$0.03B |
3.87 |
2016-06-30 |
$0.13B |
$0.03B |
3.93 |
2016-03-31 |
$0.14B |
$0.03B |
4.52 |
2015-12-31 |
$0.14B |
$0.03B |
4.79 |
2015-09-30 |
$0.15B |
$0.03B |
5.29 |
2015-06-30 |
$0.14B |
$0.03B |
4.96 |
2015-03-31 |
$0.16B |
$0.03B |
6.23 |
2014-12-31 |
$0.16B |
$0.03B |
5.31 |
2014-09-30 |
$0.13B |
$0.03B |
4.86 |
2014-06-30 |
$0.13B |
$0.03B |
4.67 |
2014-03-31 |
$0.18B |
$0.03B |
6.95 |
2013-12-31 |
$0.11B |
$0.02B |
5.83 |
2013-09-30 |
$0.09B |
$0.02B |
5.76 |
2013-06-30 |
$0.08B |
$0.01B |
6.93 |
2013-03-31 |
$0.10B |
$0.01B |
8.54 |
2012-12-31 |
$0.10B |
$0.01B |
8.73 |
2012-09-30 |
$0.11B |
$0.01B |
8.04 |
2012-06-30 |
$0.06B |
$0.02B |
3.77 |
2012-03-31 |
$0.06B |
$0.02B |
3.19 |
2011-12-31 |
$0.07B |
$0.02B |
3.47 |
2011-09-30 |
$0.08B |
$0.02B |
3.87 |
2011-06-30 |
$0.08B |
$0.02B |
4.56 |
2011-03-31 |
$0.09B |
$0.02B |
4.90 |
2010-12-31 |
$0.02B |
$0.02B |
1.13 |
2010-09-30 |
$0.02B |
$0.01B |
1.60 |
2010-06-30 |
$0.00B |
|
0.00 |
2010-03-31 |
$0.00B |
|
0.00 |
2009-09-30 |
$0.00B |
|
0.00 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Information Systems |
$0.562B |
$0.106B |
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
|